[1]
Strober, B., Sofen, H., Imafuku, S., Paul, C., Gooderham, M., Spelman, L., Seo, S.J., Passeron, T., Kisa, R.M., Berger, V., Vritzali, E., Hoyt, K., Colombo, M.J., Banerjee, S., Augustin, M., Stein Gold, L., Alexis, A., Thaçi, D., Blauvelt, A. and Lebwohl, M. 2023. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s241. DOI:https://doi.org/10.25251/skin.7.supp.241.